Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Food Sci Technol ; 59(11): 4230-4243, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-36193487

RESUMO

Brown algae have been considered a potential source of bioactives and used as a dietary supplement to manage obesity and its associated health complications. However, its effective use is limited due to heavy metals and microbial contamination, unawareness of health benefits and limited dietary exploitation. We developed, the Indian brown algae Padina tetrastromatica and barley-based anti-obesity food (AOF) and examined for microbial and heavy metal safety. Additionally, acute [0 (control), 50, 100, 200, 500 g AOF/kg diet] and sub-acute [0, 5, 50 g AOF/kg diet] doses of AOF were fed to C57BL6 mice and toxicity was examined. The physical, locomotory, hematological, biochemical parameters and histopathology were examined. Postprandial plasma and tissue levels of fucoxanthin and its metabolites were analyzed. Feeding AOF did not affect the general behavior, food and water intake, growth or survival of animals. Biochemical indices did not show any differences between AOF-fed and control groups. However, significantly lower levels of plasma cholesterol and triglycerides in groups fed 5 and 50 g of AOF/kg diet were observed. The post-mortem examination revealed no macroscopic/microscopic alteration in the vital organs. Overall, results validate that AOF is a safe and effective dietary supplement (even at higher doses of 500 g AOF/kg) to mitigate obesity. Supplementary Information: The online version contains supplementary material available at 10.1007/s13197-022-05483-4.

2.
Bioconjug Chem ; 23(5): 1003-9, 2012 May 16.
Artigo em Inglês | MEDLINE | ID: mdl-22515422

RESUMO

Dextran-coated superparamagnetic iron oxide nanoparticles (dextran-SPIO conjugates) offer the attractive possibility of enhancing MRI imaging sensitivity so that small or diffuse lesions can be detected. However, systemically injected SPIOs are rapidly removed by macrophages. We engineered embryonic cells (HEK293T) to express major macrophage scavenger receptor (SR) subtypes including SR-AI, MARCO, and endothelial receptor collectin-12. These SRs possess a positively charged collagen-like (CL) domain and they promoted SPIO uptake, while the charge neutral lipoprotein receptor SR-BI did not. In silico modeling indicated a positive net charge on the CL domain and a net negative charge on the cysteine-rich (CR) domain of MARCO and SR-AI. In vitro experiments revealed that CR domain deletion in SR-AI boosted uptake of SPIO 3-fold, while deletion of MARCO's CR domain abolished this uptake. These data suggest that future studies might productively focus on the validation and further exploration of SR charge fields in SPIO recognition.


Assuntos
Meios de Contraste/metabolismo , Dextranos/metabolismo , Macrófagos/metabolismo , Nanopartículas/metabolismo , Receptores Depuradores/metabolismo , Clonagem Molecular , Colágeno Tipo I/metabolismo , Células HEK293 , Humanos , Imageamento por Ressonância Magnética , Nanopartículas de Magnetita , Modelos Moleculares , Nanopartículas/ultraestrutura , Estrutura Terciária de Proteína , Receptores Depuradores/química , Receptores Depuradores/genética
3.
Mol Pharm ; 9(3): 539-45, 2012 Mar 05.
Artigo em Inglês | MEDLINE | ID: mdl-22243419

RESUMO

Premature recognition and clearance of nanoparticulate imaging and therapeutic agents by macrophages in the tissues can dramatically reduce both the nanoparticle half-life and delivery to the diseased tissue. Grafting nanoparticles with hydrogels prevents nanoparticulate recognition by liver and spleen macrophages and greatly prolongs circulation times in vivo. Understanding the mechanisms by which hydrogels achieve this "stealth" effect has implications for the design of long-circulating nanoparticles. Thus, the role of plasma protein absorption in the hydrogel effect is not yet understood. Short-circulating dextran-coated iron oxide nanoparticles could be converted into stealth hydrogel nanoparticles by cross-linking with 1-chloro-2,3-epoxypropane. We show that hydrogelation did not affect the size, shape and zeta potential, but completely prevented the recognition and clearance by liver macrophages in vivo. Hydrogelation decreased the number of hydroxyl groups on the nanoparticle surface and reduced the binding of the anti-dextran antibody. At the same time, hydrogelation did not reduce the absorption of cationic proteins on the nanoparticle surface. Specifically, there was no effect on the binding of kininogen, histidine-rich glycoprotein, and protamine sulfate to the anionic nanoparticle surface. In addition, hydrogelation did not prevent activation of plasma kallikrein on the metal oxide surface. These data suggest that (a) a stealth hydrogel coating does not mask charge interactions with iron oxide surface and (b) the total blockade of plasma protein absorption is not required for maintaining iron oxide nanoparticles' long-circulating stealth properties. These data illustrate a novel, clinically promising property of long-circulating stealth nanoparticles.


Assuntos
Dextranos/química , Compostos Férricos/química , Hidrogel de Polietilenoglicol-Dimetacrilato/química , Nanopartículas/química , Animais , Feminino , Complexo Ferro-Dextran/química , Cininogênios/química , Camundongos , Camundongos Endogâmicos C57BL , Ligação Proteica
4.
Adv Exp Med Biol ; 733: 115-23, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22101717

RESUMO

Superparamagnetic iron oxide (SPIO, Ferumoxides, Feridex), an important MRI intravenous contrast reagent, is efficiently recognized and eliminated by macrophages in the liver, spleen, lymph nodes and atherosclerotic lesions. The receptors that recognize nanoparticles are poorly defined and understood. Since SPIO is coated with bacterial polysaccharide dextran, it is important to know whether carbohydrate recognition plays a role in nanoparticle uptake by macrophages. Lectin-like receptors CD206 (macrophage mannose receptor) and SIGNR1 were previously shown to mediate uptake of bacterial polysaccharides. We transiently expressed receptors MGL-1, SIGNR-1 and msDectin-1 in non-macrophage 293T cells using lipofection. The expression was confirmed by reverse transcription PCR. Following incubation with the nanoparticles, the uptake in receptor-expressing cells was not statistically different compared to control cells (GFP-transfected). At the same time, expression of scavenger receptor SR-A1 increased the uptake of nanoparticles three-fold compared to GFP-transfected and control vector-transfected cells. Blocking CD206 with anti-CD206 antibody or with the ligand mannan did not affect SPIO uptake by J774.A1 macrophages. Similarly, there was no inhibition of the uptake by anti-CD11b (Mac-1 integrin) antibody. Polyanionic scavenger receptor ligands heparin, polyinosinic acid, fucoidan and dextran sulfate decreased the uptake of SPIO by J774A.1 macrophages and Kupffer cells by 60-75%. These data unambiguously show that SPIO is taken up via interaction by scavenger receptors, but not via dextran recognition by carbohydrate receptors. Understanding of nanoparticle-receptor interaction can provide guidance for the design of long circulating, non-toxic nanomedicines.


Assuntos
Dextranos/metabolismo , Macrófagos/metabolismo , Nanopartículas de Magnetita/química , Receptores Depuradores/metabolismo , Animais , Linhagem Celular , Dextranos/química , Portadores de Fármacos/química , Expressão Gênica , Humanos , Células de Kupffer/metabolismo , Lectinas Tipo C , Mananas/farmacologia , Receptor de Manose , Lectinas de Ligação a Manose , Camundongos , Receptores de Superfície Celular , Receptores Depuradores Classe A/genética , Receptores Depuradores Classe A/metabolismo
5.
Eur J Trauma Emerg Surg ; 48(4): 3327-3338, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-35192003

RESUMO

PURPOSE: Literature on outcomes after SSRF, stratified for rib fracture pattern is scarce in patients with moderate to severe traumatic brain injury (TBI; Glasgow Coma Scale ≤ 12). We hypothesized that SSRF is associated with improved outcomes as compared to nonoperative management without hampering neurological recovery in these patients. METHODS: A post hoc subgroup analysis of the multicenter, retrospective CWIS-TBI study was performed in patients with TBI and stratified by having sustained a non-flail fracture pattern or flail chest between January 1, 2012 and July 31, 2019. The primary outcome was mechanical ventilation-free days and secondary outcomes were in-hospital outcomes. In multivariable analysis, outcomes were assessed, stratified for rib fracture pattern. RESULTS: In total, 449 patients were analyzed. In patients with a non-flail fracture pattern, 25 of 228 (11.0%) underwent SSRF and in patients with a flail chest, 86 of 221 (38.9%). In multivariable analysis, ventilator-free days were similar in both treatment groups. For patients with a non-flail fracture pattern, the odds of pneumonia were significantly lower after SSRF (odds ratio 0.29; 95% CI 0.11-0.77; p = 0.013). In patients with a flail chest, the ICU LOS was significantly shorter in the SSRF group (beta, - 2.96 days; 95% CI - 5.70 to - 0.23; p = 0.034). CONCLUSION: In patients with TBI and a non-flail fracture pattern, SSRF was associated with a reduced pneumonia risk. In patients with TBI and a flail chest, a shorter ICU LOS was observed in the SSRF group. In both groups, SSRF was safe and did not hamper neurological recovery.


Assuntos
Lesões Encefálicas Traumáticas , Tórax Fundido , Pneumonia , Fraturas das Costelas , Lesões Encefálicas Traumáticas/complicações , Lesões Encefálicas Traumáticas/terapia , Tórax Fundido/cirurgia , Fixação Interna de Fraturas , Humanos , Tempo de Internação , Estudos Retrospectivos , Fraturas das Costelas/complicações
6.
J Trauma Acute Care Surg ; 90(3): 492-500, 2021 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-33093293

RESUMO

BACKGROUND: Outcomes after surgical stabilization of rib fractures (SSRF) have not been studied in patients with multiple rib fractures and traumatic brain injury (TBI). We hypothesized that SSRF, as compared with nonoperative management, is associated with favorable outcomes in patients with TBI. METHODS: A multicenter, retrospective cohort study was performed in patients with rib fractures and TBI between January 2012 and July 2019. Patients who underwent SSRF were compared to those managed nonoperatively. The primary outcome was mechanical ventilation-free days. Secondary outcomes were intensive care unit length of stay and hospital length of stay, tracheostomy, occurrence of complications, neurologic outcome, and mortality. Patients were further stratified into moderate (GCS score, 9-12) and severe (GCS score, ≤8) TBI. RESULTS: The study cohort consisted of 456 patients of which 111 (24.3%) underwent SSRF. The SSRF was performed at a median of 3 days, and SSRF-related complication rate was 3.6%. In multivariable analyses, there was no difference in mechanical ventilation-free days between the SSRF and nonoperative groups. The odds of developing pneumonia (odds ratio [OR], 0.59; 95% confidence interval [95% CI], 0.38-0.98; p = 0.043) and 30-day mortality (OR, 0.32; 95% CI, 0.11-0.91; p = 0.032) were significantly lower in the SSRF group. Patients with moderate TBI had similar outcome in both groups. In patients with severe TBI, the odds of 30-day mortality was significantly lower after SSRF (OR, 0.19; 95% CI, 0.04-0.88; p = 0.034). CONCLUSION: In patients with multiple rib fractures and TBI, the mechanical ventilation-free days did not differ between the two treatment groups. In addition, SSRF was associated with a significantly lower risk of pneumonia and 30-day mortality. In patients with moderate TBI, outcome was similar. In patients with severe TBI a lower 30-day mortality was observed. There was a low SSRF-related complication risk. These data suggest a potential role for SSRF in select patients with TBI. LEVEL OF EVIDENCE: Therapeutic, level IV.


Assuntos
Lesões Encefálicas Traumáticas/complicações , Fixação de Fratura , Fraturas Múltiplas/complicações , Fraturas Múltiplas/cirurgia , Fraturas das Costelas/complicações , Fraturas das Costelas/cirurgia , Adulto , Lesões Encefálicas Traumáticas/diagnóstico , Lesões Encefálicas Traumáticas/terapia , Cuidados Críticos , Feminino , Fraturas Múltiplas/diagnóstico , Humanos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Razão de Chances , Complicações Pós-Operatórias/epidemiologia , Respiração Artificial , Estudos Retrospectivos , Fraturas das Costelas/diagnóstico , Resultado do Tratamento
7.
Sci Adv ; 6(45)2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-33148638

RESUMO

Zika virus (ZIKV) is associated with congenital malformations in infants born to infected mothers, and with Guillain-Barré syndrome in infected adults. Development of ZIKV vaccines has focused predominantly on the induction of neutralizing antibodies, although a suboptimal antibody response may theoretically enhance disease severity through antibody-dependent enhancement (ADE). Here, we report induction of a protective anti-ZIKV CD8+ T cell response in the HLA-B*0702 Ifnar1-/- transgenic mice using an alphavirus-based replicon RNA vaccine expressing ZIKV nonstructural protein NS3, a potent T cell antigen. The NS3 vaccine did not induce a neutralizing antibody response but elicited polyfunctional CD8+ T cells that were necessary and sufficient for preventing death in lethally infected adult mice and fetal growth restriction in infected pregnant mice. These data identify CD8+ T cells as the major mediators of ZIKV NS3 vaccine-induced protection and suggest a new strategy to develop safe and effective anti-flavivirus vaccines.


Assuntos
Infecção por Zika virus , Zika virus , Animais , Anticorpos Neutralizantes , Linfócitos T CD8-Positivos , Humanos , Camundongos , Vacinas Sintéticas , Vacinas de mRNA
8.
Nanomedicine ; 5(1): 73-82, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18829396

RESUMO

We have used tumor-homing peptides to target abraxane, a clinically approved paclitaxel-albumin nanoparticle, to tumors in mice. The targeting was accomplished with two peptides, CREKA and LyP-1 (CGNKRTRGC). Fluorescein (FAM)-labeled CREKA-abraxane, when injected intravenously into mice bearing MDA-MB-435 human cancer xenografts, accumulated in tumor blood vessels, forming aggregates that contained red blood cells and fibrin. FAM-LyP-1-abraxane co-localized with extravascular islands expressing its receptor, p32. Self-assembled mixed micelles carrying the homing peptide and the label on different subunits accumulated in the same areas of tumors as LyP-1-abraxane, showing that Lyp-1 can deliver intact nanoparticles into extravascular sites. Untargeted, FAM-abraxane was detected in the form of a faint meshwork in tumor interstitium. LyP-1-abraxane produced a statistically highly significant inhibition of tumor growth compared with untargeted abraxane. These results show that nanoparticles can be effectively targeted into extravascular tumor tissue and that targeting can enhance the activity of a therapeutic nanoparticle.


Assuntos
Neoplasias da Mama/tratamento farmacológico , Nanopartículas/administração & dosagem , Nanopartículas/uso terapêutico , Paclitaxel/administração & dosagem , Paclitaxel/uso terapêutico , Paclitaxel Ligado a Albumina , Albuminas/administração & dosagem , Albuminas/uso terapêutico , Animais , Neoplasias da Mama/patologia , Linhagem Celular Tumoral , Portadores de Fármacos/administração & dosagem , Portadores de Fármacos/química , Humanos , Imuno-Histoquímica , Camundongos , Camundongos Nus , Peptídeos/administração & dosagem , Peptídeos/química
9.
J Med Chem ; 48(11): 3784-95, 2005 Jun 02.
Artigo em Inglês | MEDLINE | ID: mdl-15916430

RESUMO

Inspired by the previously reported superior gene transfer efficacies of amine headgroup-containing cationic lipids to their hydroxy counterparts, in the present structure-activity investigation we have compared the relative in vitro gene transfer efficacies of eight newly synthesized structural analogues of our previously reported lipids 1-4, namely the four 3,4-diaminopyrrolidinium chloride structural analogues (lipids 9-12, Chart 1) and the N-BOC-protected precursors of these amine analogues (lipids 5-8, Chart 1) with our previously reported lipids 1-4 (Chart 1) in five cultured cell lines. In contrast to the above-mentioned earlier reports, except for the superior or comparable transfection efficacies of the diaminopyrrolidinium lipids with distearyl and stearyloleyl chains (lipid 11 and 12 respectively, Chart 1) in MCF-7 and HEK293T cells, the relative transfection efficacies of the other diamino analogues were found to be much lower than their dihydroxy counterparts. The results of the DNase I sensitivity assays indicate that enhanced degradation of DNA associated with lipids 9-12 by cellular DNase I might play an important role behind their seriously compromised transfection efficacies. In addition, the present structure-activity investigation revealed a strikingly cell tropic transfection behavior of lipid 6 (Chart 1). While lipids 5, 7, and 8 were found to be either poor or essentially incompetent in transfecting all the five cells, lipid 6 was remarkably efficacious in transfecting kidney cells (COS-1 and HEK293T cells) at lipid:DNA charge ratios 3:1 and 1:1 when used in combination with equimolar amounts of DOPE and DOPC.


Assuntos
Técnicas de Transferência de Genes , Lipídeos/síntese química , Pirrolidinas/síntese química , Compostos de Amônio Quaternário/síntese química , Animais , Cátions , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Chlorocebus aethiops , Cricetinae , Cricetulus , DNA/administração & dosagem , DNA/química , Desoxirribonuclease I/química , Genes Reporter , Humanos , Rim/citologia , Rim/metabolismo , Lipídeos/química , Lipídeos/farmacologia , Lipossomos , Nanoestruturas , Pirrolidinas/química , Pirrolidinas/farmacologia , Compostos de Amônio Quaternário/química , Compostos de Amônio Quaternário/farmacologia , Relação Estrutura-Atividade , Transfecção , beta-Galactosidase/biossíntese , beta-Galactosidase/genética
10.
Mol Biol Cell ; 25(17): 2539-41, 2014 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-25169831

RESUMO

This article presents one scientist's perspective on the transition from life at the bench to an editorial career.


Assuntos
Mobilidade Ocupacional , Ocupações , Editoração , Pesquisa
11.
J Cell Biol ; 199(1): 7-8, 2012 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-23027898

RESUMO

How does basic cell biology contribute to biomedicine? A new series of Features in JCB provides a cross section of compelling examples of how basic cell biology findings can lead to therapeutics. These articles highlight the fruitful, essential, and increasingly prominent bridge that exists between cell biology and the clinic.


Assuntos
Pesquisa Biomédica , Tecnologia Biomédica , Biologia Celular , Animais , Doença/genética , Humanos
12.
Expert Opin Drug Deliv ; 8(3): 343-57, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21291354

RESUMO

INTRODUCTION: Intravenously injected nanoparticles, like any other foreign pathogen that enters the body, encounter multiple lines of defense intended to neutralize and eliminate the invading substance. Adsorption of plasma proteins on the nanoparticle surface is the first barrier of defense, which could lead to physical changes in the formulation, such as aggregation and charge neutralization, biochemical activation of defense cascades, and trigger elimination by multiple types of phagocytic cell. AREAS COVERED: In this review, recent knowledge on the mechanisms that govern the interactions of nanoparticles (micelles, liposomes, polymeric and inorganic nanoparticles) with plasma proteins is discussed. In particular, the role of the nanoparticle surface properties and protective polymer coating in these interactions is described. The mechanisms of protein adsorption on different nanoparticles are analyzed and the implications on the clearance, toxicity and efficacy of drug delivery are discussed. The review provides readers with the biological insight into the plasma/blood interactions of nanoparticles. EXPERT OPINION: The immune recognition of nanoparticles can seriously affect the drug delivery efficacy and toxicity. There is at present not enough knowledge on the mechanisms that dictate the nanoparticle immune recognition and stability in the biological milieu. Understanding the mechanisms of recognition will become an important part of nanoparticle design.


Assuntos
Proteínas Sanguíneas/química , Sistemas de Liberação de Medicamentos , Nanopartículas/química , Química Farmacêutica , Humanos , Ligação Proteica
13.
PLoS One ; 6(8): e23840, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21886829

RESUMO

BACKGROUND: Resistance to anoikis, which is defined as apoptosis induced by loss of integrin-mediated cell attachment to the extracellular matrix, is a determinant of tumor progression and metastasis. We have previously identified the mitochondrial Bit1 (Bcl-2 inhibitor of transcription) protein as a novel anoikis effector whose apoptotic function is independent from caspases and is uniquely controlled by integrins. In this report, we examined the possibility that Bit1 is suppressed during tumor progression and that Bit1 downregulation may play a role in tumor metastasis. METHODOLOGY/PRINCIPAL FINDINGS: Using a human breast tumor tissue array, we found that Bit1 expression is suppressed in a significant fraction of advanced stages of breast cancer. Targeted disruption of Bit1 via shRNA technology in lowly aggressive MCF7 cells conferred enhanced anoikis resistance, adhesive and migratory potential, which correlated with an increase in active Extracellular kinase regulated (Erk) levels and a decrease in Erk-directed phosphatase activity. These pro-metastasis phenotypes were also observed following downregulation of endogenous Bit1 in Hela and B16F1 cancer cell lines. The enhanced migratory and adhesive potential of Bit1 knockdown cells is in part dependent on their high level of Erk activation since down-regulating Erk in these cells attenuated their enhanced motility and adhesive properties. The Bit1 knockdown pools also showed a statistically highly significant increase in experimental lung metastasis, with no differences in tumor growth relative to control clones in vivo using a BALB/c nude mouse model system. Importantly, the pulmonary metastases of Bit1 knockdown cells exhibited increased phospho-Erk staining. CONCLUSIONS/SIGNIFICANCE: These findings indicate that downregulation of Bit1 conferred cancer cells with enhanced anoikis resistance, adhesive and migratory properties in vitro and specifically potentiated tumor metastasis in vivo. These results underscore the therapeutic importance of restoring Bit1 expression in cancer cells to circumvent metastasis at least in part through inhibition of the Erk pathway.


Assuntos
Neoplasias da Mama/patologia , Hidrolases de Éster Carboxílico/fisiologia , Regulação Neoplásica da Expressão Gênica , Neoplasias Pulmonares/secundário , Animais , Anoikis , Hidrolases de Éster Carboxílico/genética , Linhagem Celular Tumoral , Progressão da Doença , Regulação para Baixo/genética , Feminino , Humanos , Sistema de Sinalização das MAP Quinases , Camundongos , Camundongos Endogâmicos BALB C , Metástase Neoplásica , Neoplasias/patologia
14.
Science ; 328(5981): 1031-5, 2010 May 21.
Artigo em Inglês | MEDLINE | ID: mdl-20378772

RESUMO

Poor penetration of anticancer drugs into tumors can be an important factor limiting their efficacy. We studied mouse tumor models to show that a previously characterized tumor-penetrating peptide, iRGD, increased vascular and tissue permeability in a tumor-specific and neuropilin-1-dependent manner, allowing coadministered drugs to penetrate into extravascular tumor tissue. Importantly, this effect did not require the drugs to be chemically conjugated to the peptide. Systemic injection with iRGD improved the therapeutic index of drugs of various compositions, including a small molecule (doxorubicin), nanoparticles (nab-paclitaxel and doxorubicin liposomes), and a monoclonal antibody (trastuzumab). Thus, coadministration of iRGD may be a valuable way to enhance the efficacy of anticancer drugs while reducing their side effects, a primary goal of cancer therapy research.


Assuntos
Antineoplásicos/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Neoplasias/tratamento farmacológico , Oligopeptídeos/administração & dosagem , Paclitaxel Ligado a Albumina , Albuminas/administração & dosagem , Albuminas/farmacocinética , Albuminas/uso terapêutico , Animais , Anticorpos Monoclonais/administração & dosagem , Anticorpos Monoclonais/farmacocinética , Anticorpos Monoclonais/uso terapêutico , Anticorpos Monoclonais Humanizados , Antineoplásicos/farmacocinética , Antineoplásicos/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/farmacocinética , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Permeabilidade Capilar/efeitos dos fármacos , Doxorrubicina/administração & dosagem , Doxorrubicina/farmacocinética , Doxorrubicina/uso terapêutico , Humanos , Lipossomos , Camundongos , Neoplasias/irrigação sanguínea , Neoplasias/metabolismo , Neuropilina-1/metabolismo , Oligopeptídeos/metabolismo , Oligopeptídeos/farmacocinética , Oligopeptídeos/farmacologia , Paclitaxel/administração & dosagem , Paclitaxel/farmacocinética , Paclitaxel/uso terapêutico , Permeabilidade , Trastuzumab , Ensaios Antitumorais Modelo de Xenoenxerto
15.
Cancer Cell ; 16(6): 510-20, 2009 Dec 08.
Artigo em Inglês | MEDLINE | ID: mdl-19962669

RESUMO

Poor penetration of drugs into tumors is a major obstacle in tumor treatment. We describe a strategy for peptide-mediated delivery of compounds deep into the tumor parenchyma that uses a tumor-homing peptide, iRGD (CRGDK/RGPD/EC). Intravenously injected compounds coupled to iRGD bound to tumor vessels and spread into the extravascular tumor parenchyma, whereas conventional RGD peptides only delivered the cargo to the blood vessels. iRGD homes to tumors through a three-step process: the RGD motif mediates binding to alphav integrins on tumor endothelium and a proteolytic cleavage then exposes a binding motif for neuropilin-1, which mediates penetration into tissue and cells. Conjugation to iRGD significantly improved the sensitivity of tumor-imaging agents and enhanced the activity of an antitumor drug.


Assuntos
Antineoplásicos/farmacocinética , Nanopartículas , Neoplasias Experimentais/metabolismo , Neoplasias/metabolismo , Sequência de Aminoácidos , Animais , Integrinas/metabolismo , Camundongos , Camundongos Nus , Neoplasias/patologia , Neoplasias Experimentais/patologia , Neuropilina-1/metabolismo , Oligopeptídeos/metabolismo
16.
Med Res Rev ; 27(5): 696-722, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17022036

RESUMO

The clinical success of gene therapy is critically dependent on the development of efficient and safe gene delivery reagents, popularly known as "transfection vectors." The transfection vectors commonly used in gene therapy are mainly of two types: viral and non-viral. The efficiencies of viral transfection vectors are, in general, superior to their non-viral counterparts. However, the myriads of potentially adverse immunogenic aftermaths associated with the use of viral vectors are increasingly making the non-viral gene delivery reagents as the vectors of choice. Among the existing arsenal of non-viral gene delivery reagents, the distinct advantages associated with the use of cationic transfection lipids include their: (a) robust manufacture; (b) ease in handling and preparation techniques; (c) ability to inject large lipid:DNA complexes; and (d) low immunogenic response. The present review highlights the major achievements in the area of designing efficacious cationic transfection lipids, some of the more recent advances in the field of cationic liposomes-mediated gene transfer and targeted gene delivery, some unresolved issues and challenges in liposomal gene delivery, and future promises of cationic liposomes as gene-carriers in non-viral gene therapy.


Assuntos
Terapia Genética , Lipossomos/química , Transfecção/tendências , Animais , Cátions/química , Vetores Genéticos/química , Humanos , Lipossomos/metabolismo , Transfecção/métodos
17.
J Bacteriol ; 189(2): 491-500, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17085558

RESUMO

Toxin-antitoxin (TA) loci, which were initially characterized as plasmid stabilization agents, have in recent years been detected on the chromosomes of numerous free-living bacteria. Vibrio cholerae, the causative agent of cholera, contains 13 putative TA loci, all of which are clustered within the superintegron on chromosome II. Here we report the characterization of the V. cholerae higBA locus, also known as VCA0391/2. Deletion of higA alone was not possible, consistent with predictions that it encodes an antitoxin, and biochemical analyses confirmed that HigA interacts with HigB. Transient exogenous expression of the toxin HigB dramatically slowed growth of V. cholerae and Escherichia coli and reduced the numbers of CFU by several orders of magnitude. HigB toxicity could be counteracted by simultaneous or delayed production of HigA, although HigA's effect diminished as the delay lengthened. Transcripts from endogenous higBA increased following treatment of V. cholerae with translational inhibitors, presumably due to reduced levels of HigA, which represses the higBA locus. However, no higBA-dependent cell death was observed in response to such stimuli. Thus, at least under the conditions tested, activation of endogenous HigB does not appear to be bactericidal.


Assuntos
Toxina da Cólera/genética , Regulação Bacteriana da Expressão Gênica , Vibrio cholerae/genética , Sequência de Aminoácidos , Sequência de Bases , Toxina da Cólera/metabolismo , Cromossomos Bacterianos , Eletroforese em Gel de Poliacrilamida , Escherichia coli/genética , Escherichia coli/metabolismo , Óperon Lac/genética , Viabilidade Microbiana/genética , Dados de Sequência Molecular , Mutação , Plasmídeos/genética , Homologia de Sequência de Aminoácidos , Vibrio cholerae/metabolismo
18.
Methods ; 38(1): 29-34, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16343934

RESUMO

Microtubules are dynamic polymers that participate in multiple cellular processes such as vesicular transport and cell division. Microtubule dynamics alter dramatically during the cell cycle. An excellent system to study microtubule dynamics is Xenopus egg extracts since it is a system that is open to manipulation. The extracts can be cycled between mitosis and interphase allowing the study of microtubules in these phases as well as during cell cycle transitions. Here, we provide simple assays to study microtubules in extracts and in vitro using purified components. Protocols are provided for the purification of frog tubulin, microtubule pelleting from extracts and in vitro, assembly of microtubule structures in extracts, and isolation of microtubule-associated proteins from extract. These methods can be used to analyze the effect of a protein of interest on the microtubule cytoskeleton.


Assuntos
Ciclo Celular/fisiologia , Fracionamento Celular/métodos , Microtúbulos/química , Microtúbulos/ultraestrutura , Animais , Extratos Celulares , Eletroforese em Gel de Poliacrilamida , Feminino , Masculino , Proteínas Associadas aos Microtúbulos/isolamento & purificação , Microtúbulos/metabolismo , Óvulo/metabolismo , Óvulo/ultraestrutura , Tubulina (Proteína)/isolamento & purificação , Xenopus
19.
Bioconjug Chem ; 17(1): 159-71, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16417265

RESUMO

Recently, we demonstrated that covalent grafting of an endosome-disrupting single histidine functionality in the headgroup region imparts high gene transfer properties to cationic amphiphiles (Kumar, V. V., et al. Gene Ther. 2003, 10, 1206-1215). However, whether covalent attachment of multiple histidine functionalities in the headgroup region are capable of further enhancing the gene transfer efficacies of cationic amphiphiles remains to be explored. To this end, herein, we report on the design, syntheses, physicochemical characterizations, in vitro gene transfer properties, and serum compatibilities of three novel nontoxic cationic transfection amphiphiles containing mono-, di-, and tri-histidine functionalities in their headgroup regions (lipids 1-3) in multiple cultured cells. Significantly, findings in both the reporter gene expression assay and the whole cell histochemical X-gal staining assay support the notion that there is no linear correlation between the in vitro transfection efficacies and the number of histidine functionalities in the polar headgroup regions for histidinylated cationic amphiphiles. The relative gene transfer efficiencies, as well as the serum compatibilities, of the present histidinylated cationic amphiphiles were found to be strikingly dependent on the medium of lipoplex formation. Most importantly, high serum compatibilities (up to 50% added serum) of the lipoplexes of lipids 1 and 3 make them promising nonviral transfection vectors for future systemic applications.


Assuntos
Histidina/química , Lipídeos/administração & dosagem , Lipídeos/química , Lipossomos , Transfecção , Animais , Células CHO , Células COS , Linhagem Celular , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Chlorocebus aethiops , Cricetinae , Cricetulus , DNA/administração & dosagem , DNA/metabolismo , Vetores Genéticos , Humanos , Plasmídeos , Soro , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA